ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Worldwide Synthetic Biology Tools Market 2013-2023: Upstream Raw Materials Sources, Downstream Buyers and … – Exclusive Reportage

Worldwide Synthetic Biology Tools Market 2013-2023: Upstream Raw Materials Sources, Downstream Buyers and …Exclusive ReportageSynthetic Biology Tools Market report provides key statistics on the market status of the Synthetic Biology Tools Manufactur… Continue reading

2018-05-21 Michael Zand NEWS

A teen with Duchenne reports improvement on Solid’s gene therapy, and investors take notice – STAT

Continue reading

2018-05-21 Michael Zand NEWS

Are the anti-GMO activists in Ghana following CRISPR? – GhanaWeb

GhanaWebAre the anti-GMO activists in Ghana following CRISPR?GhanaWebI am only wondering if those spreading the misinformation are currently following the recent “super” GMO technique referred to as Clusters of Regularly Interspaced Short Palindromic … Continue reading

2018-05-21 Michael Zand NEWS

Flow of cerebrospinal fluid found to be key signal for neural stem cell renewal – News-Medical.net


STAT

A teen with Duchenne reports improvement on Solid’s gene therapy, and investors take notice
STAT
14-year-old boy with Duchenne muscular dystrophy 1 has regained some strength and function in his muscles following treatment with an experimental gene therapy from Solid Biosciences, the boy’s father tells STAT. And although it’s just a single case …

Continue reading

2018-05-21 Michael Zand NEWS

Ask the Expert: How does a stem cell transplant work? – The Daily Progress

Ask the Expert: How does a stem cell transplant work?The Daily ProgressA. Stem cell transplants seek to cure patients with blood cancers, such as leukemia, lymphoma and myeloma. For children, these transplants also can be used to cure certain genetic d… Continue reading

2018-05-20 Michael Zand NEWS

Uniqure Notches Bullish Initiation On Gene Therapy Prospects – Benzinga


News-Medical.net

Flow of cerebrospinal fluid found to be key signal for neural stem cell renewal
News-Medical.net
Stem cells in the brain can divide and mature into neurons participating in various brain functions, including memory. In a paper published in the journal ‘Cell Stem Cell‘, scientists at Helmholtz Zentrum München and Ludwig-Maximilians-Universität …
Novel robotic system can grow mini human organsDeccan Herald
Stem Cell Cure Offering Safe and Effective Stem Cell Treatments for Muscular DystrophyDigital Journal
2022 Animal Stem Cell Therapy Market: Global Manufacturers Analysis, Revenue, Market Share, Types, ApplicationsExpert Consulting
Technical Progress –CryptoNexa
all 41 news articles »
Continue reading

2018-05-20 Michael Zand NEWS

Uniqure Notches Bullish Initiation On Gene Therapy Prospects – Benzinga


Benzinga

Uniqure Notches Bullish Initiation On Gene Therapy Prospects
Benzinga
Uniqure’s dominant gene therapy platform with an AAVS vector; its potential “best-in-class” lead gene therapy candidate AMT-061 for treating hemophilia B; and pipeline optionality for treating Huntington’s and genetically driven heart disease create a …

and more »

Continue reading

2018-05-20 Michael Zand NEWS

AUA 2018: Selection of Appropriate Genitourinary Cancers for Immunotherapy – UroToday

AUA 2018: Selection of Appropriate Genitourinary Cancers for ImmunotherapyUroTodayHe highlighted FDA approved indications for immunotherapy in genitourinary oncology, including for urothelial carcinoma and clear cell renal cell carcinoma. Additionally,… Continue reading

2018-05-20 Michael Zand NEWS
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Benzinga

Uniqure Notches Bullish Initiation On Gene Therapy Prospects
Benzinga
Uniqure’s dominant gene therapy platform with an AAVS vector; its potential “best-in-class” lead gene therapy candidate AMT-061 for treating hemophilia B; and pipeline optionality for treating Huntington’s and genetically driven heart disease create a …

and more »